We have recently reported the expression of functional cannabinoid CB 2 receptors (CB 2 Rs) in midbrain dopamine (DA) neurons in mice. However, little is known whether CB 2 Rs are similarly expressed in rat brain because significant species differences in CB 2 R structures and expression are found. In situ hybridization and immunohistochemical assays detected CB 2 gene and receptors in DA neurons of the ventral tegmental area (VTA), which was up-regulated in cocaine self-administration rats. Electrophysiological studies demonstrated that activation of CB 2 Rs by JWH133 inhibited VTA DA neuronal firing in single dissociated neurons. Systemic administration of JWH133 failed to alter, while local administration of JWH133 into the nucleus accumbens inhibited cocaine-enhanced extracellular DA and i.v. cocaine selfadministration. This effect was blocked by AM630, a selective CB 2 R antagonist. These data suggest that CB 2 Rs are expressed in VTA DA neurons and functionally modulate DA neuronal activities and cocaine self-administration behavior in rats.
INTRODUCTION
Marijuana has been used by humans for centuries for medical and recreational purposes. However, the neurobiological mechanisms underlying marijuana's actions are still not fully understood (Maldonado et al. 2011 ). Δ 9 -tetrahydrocannabinol (Δ 9 -THC) is the major psychoactive ingredient of marijuana . The pharmacological action of Δ 9 -THC is mediated predominantly by activation of cannabinoid CB 1 and CB 2 receptors (CB 1 Rs and CB 2 Rs) (Maldonado et al. 2011; . Because CB 1 Rs are highly expressed in the brain (Glass & Felder 1997; Mackie 2005 Mackie , 2008 , while CB 2 Rs are found mainly in peripheral tissues (Griffin et al. 2000; Munro et al. 1993) , it has heretofore been generally believed that the central psychoactive effects of Δ 9 -THC or cannabis are mediated by activation of brain CB 1 Rs (Howlett et al. 2002; Maldonado et al. 2011) . However, this longheld view has been challenged by recent findings that CB 2 Rs are also expressed in mouse brain and functionally involved in several dopamine (DA)-related CNS disorders such as Parkinson's disease Ortega-Alvaro et al. 2011) , depression (Garcia-Gutierrez et al. 2010) , anxiety , 2012 and schizophrenia (Navarrete et al. 2012; Ortega-Alvaro et al. 2011) .
In addition, brain CB 2 Rs are recently reported to be involved in drug abuse and addiction. Systemic or intracranial local administration of CB 2 R agonists inhibits cocaine or alcohol self-administration, cocaine-induced or alcohol-induced conditioned place preference (CPP) and alcohol-induced locomotor sensitization in mice (Aloverexpression of CB 2 Rs in mouse brain decreases cocaine self-administration and cocaine-enhanced locomotion (Aracil-Fernandez et al. 2012) . Further, genetic deletion of CB 2 Rs (CB 2 -KO mice) caused increased response to ethanol (Ortega-Alvaro et al. 2015) , but decreased response to nicotine in the CPP and self-administration paradigms (Ignatowska-Jankowska et al. 2013; Navarrete et al. 2013 ). More recent research suggests that CB 2 Rs are expressed in midbrain DA neurons in mice and activation of CB 2 Rs in the ventral tegmental area (VTA) inhibits DA neuronal firing and cocaine self-administration (Aracil-Fernandez et al. 2012; Xi et al. 2011; Zhang et al. 2014; Zhang et al. 2015) . In addition, CB 2 Rs were also expressed in pyramidal neurons and modulate excitatory synaptic transmission in the hippocampus of mice .
In contrast to the previously mentioned findings in mice, systemic administration of CB 2 R agonists or antagonists fail to alter cocaine or nicotine self-administration under fixed-ratio reinforcement schedules in rats (Adamczyk et al. 2012; Gamaleddin et al. 2012) . Paradoxically, CB 2 R antagonists were reported to attenuate cocaine-induced reinstatement of drug-seeking behavior (Adamczyk et al. 2012 ) and cocaine-induced conditioned locomotion in rats (Blanco-Calvo et al. 2014) . The reasons underlying such conflicting findings in rats and mice are unclear. We have recently reported species differences in the structure and expression of CB 2 genes and receptors in rats and mice Zhang et al. 2015) , suggesting that the findings observed in one species (mice) cannot be simply generalized to another species (rats). One hypothesis is that brain CB 2 Rs may have different cellular distributions in the brains of rats and mice and therefore produce different behavioral effects in the previously mentioned experiments. To the best of our knowledge, there is no evidence demonstrating whether CB 2 Rs are expressed in VTA DA neurons in rats.
In the present study, we first used duplex in situ hybridization (ISH), quantitative RT-PCR and double-label immunohistochemistry (IHC) assays to study CB 2 R gene and receptor expression in the brain and in VTA DA neurons in rats. We then examined whether cocaine self-administration alters brain CB 2 R expression and whether the selective CB 2 R agonist JWH133 alters VTA DA neuronal firing in single dissociated neurons. Lastly, we examined whether systemic or local administration of JWH133 into the nucleus accumbens (NAc) alters cocaine-enhanced extracellular DA and i.v. cocaine self-administration in rats.
MATERIALS AND METHODS

Animals
Male Long-Evans rats (Charles River, Raleigh, NC) were used in the present study. Animals were housed in a fully accredited animal facility and were maintained with food and water available in the home cage. The experimental procedures followed the Guide for the Care and Use of Laboratory Animals of the US National Research Council (1996) and were approved by the Animal Care and Use Committee of the National Institute on Drug Abuse or by the Institutional Animal Care and Use Committee of the Barrow Neurological Institute (for the electrophysiological experiments). Wistar rats were used for the electrophysiological experiments based on the availability of this strain in Dr. Wu's laboratory. This should not be a concern because there is little evidence demonstrating that CB 2 Rs display strain differences in receptor structure and function (Zhang et al. 2015) .
EXPERIMENT 1: RNASCOPE IN SITU HYBRIDIZATION ASSAY
Drug naïve rats and cocaine self-administration rats (refer to procedures for cocaine self-administration below under 'Experiment 6' were deeply anesthetized 24 hours after the last cocaine self-administration with 100 mg/kg pentobarbital and transcardially perfused with saline to remove all blood from the brain. Whole brain tissues were removed and snap frozen on dry ice. The fresh frozen tissue sections (12 μm thick) were mounted on positively charged microscopic glass slides (Thermo Fisher Scientific, Waltham, MA). Both the CB 2 R RNA probe (1935-2843 bp of the Rattus norvegicus CB 2 R, located on 3′ UTR, NM001164142.2) and dopamine transporter (DAT) probe (827-1913 bp of Rattus norvegicus solute carrier family 6, NM_012694.2) were designed and provided by Advanced Cell Diagnostics, Inc. (Hayward, CA). The experimental procedures followed the manufacturer's instructions. Stained slides were cover-slipped with fluorescent mounting medium (ProLong Gold Antifade Reagent, P36930, Thermo Fisher Scientific, Waltham, MA) and scanned into digital images using an Olympus FluoView FV1000 confocal microscope (Olympus Corporation of the Americas, Center Valley, PA). For each sample, three adjacent sections were stained using the CB 2 and DAT RNAscope probes. Ubiquitin C was used as an endogenous positive control to assess RNA probe integrity. The bacterial gene dapB served as a negative control to assess background staining (Wang et al. 2012) .
RNAscope fluorescent images were captured at 40× magnification using manufacturer-provided software on an Olympus FluoView FV1000 confocal microscope. Images were saved as 16-bit TIFF files and enhanced by using Adobe Photoshop CS5 software for analysis. ImageJ software was used to analyze the fluorescent particles. The same parameters were used to quantify the fluorescent particles or fluorescent 'dots'. Individual DA neurons were identified based on DAT staining. Pixels in each DA neuron were counted. Each pixel is assumed to represent a single molecule of CB 2 mRNA (Wang et al. 2012 ).
EXPERIMENT 2: QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION
The general procedures for quantitative real-time polymerase chain reaction (qRT-PCR) assay of brain CB 2 mRNA were as described previously ). Three groups of rats (i.e. drug naïve, oral sucrose self-administration and i.v. cocaine self-administration) were used to study the effects of cocaine or sucrose self-administration on brain CB 2 mRNA expression. After 4 weeks of i.v. cocaine (0.5 mg/kg/infusion, 3 hours per session) or oral sucrose (0.1 ml 5 percent sucrose solution per delivery) self-administration, rat brains were perfused with saline at 24 hours after the last cocaine or sucrose self-administration. Brains were then removed, and the prefrontal cortex, striatum and midbrain were dissected. A rat CB 2 TaqMan probe (TGGGCCCAGTCCT) that recognizes the conjunction region of encoding exons 2 and 3 was used to detect CB 2 mRNA expression in each brain region using the forward primer (GCCACCCAGCAAACATCTAT) and reverse primer (GACAGGCTTTGGCTGCTTCTAC). Rat β-actin-mRNA was used as an endogenous control.
EXPERIMENT 3: IMMUNOHISTOCHEMISTRY ASSAY
We used the Alomone CB 2 R antibody (ACR-002, Alomone Labs, Jerusalem, Israel) to detect CB 2 R-immunostaining in VTA DA neurons. The epitope of this antibody is located at the intracellular third loop (residues 228-242). Compared with many other antibodies, this antibody displayed a high degree of CB 2 R specificity (Zhang et al. 2014) . After brain perfusion, the brains were removed and placed in 20 percent sucrose phosphate buffer at 4°C overnight. Coronal sections were cut at 10 μm on a cryostat (CM3050S, Leica Microsystems, Nussloch, Germany). Midbrain sections containing the VTA were blocked and floated in 5 percent BSA and 0.5 percent Triton X-100 phosphate buffer for 2 hour at room temperature before being incubated with primary antibodies.
Immunohistochemistry assays were performed using Alomone CB 2 antibody (1:250) and TH antibody (1:500) to detect CB 2 R-immunostaining in VTA DA neurons. After washes, sections were further incubated with a mixture of the secondary antibodies-Alexa Fluor 488 goat antirabbit for CB 2 Rs and Alexa Fluor 568 goat antimouse for TH in 5 percent BSA and 0.5 percent Triton X-100 phosphate buffer at room temperature for 2 hours. Sections were then washed, mounted and cover slipped. Fluorescent images were taken with a fluorescence microscope (Nikon Eclipse 80i, Melville, NY, USA) or an Olympus FluoView FV1000 confocal microscope (Olympus Corporation of the Americas, Center Valley, PA).
EXPERIMENT 4: ELECTROPHYSIOLOGY STUDY
To determine whether functional CB2Rs are expressed in VTA DA neurons in rats, we employed perforated (amphotericin B) patch-clamp recording in single dissociated VTA DA neurons, which were obtained through an enzymatic/mechanical dissociation process as described previously (Wu et al. 2004; Yang et al. 2009 ). Phenotypic identification of DA neurons was based on the following three criteria: (i) electrophysiology: DA neurons exhibit low spontaneous firing rates (1-3 Hz) with long action potential (AP) duration and a distinctive H-current; (ii) pharmacology: DA neuron firing is inhibited by DA or D 2 receptor agonists; and (iii) IHC staining: recorded neurons were TH-positive. Coronal midbrain slices (400 μm thickness) were prepared from 14-to 21-day-old rats as described previously (Wu et al. 2004; Yang et al. 2009 ). Briefly, under isoflurane anesthesia, brain tissue was quickly removed and bathed in ice-cold (4°C) artificial cerebrospinal fluid (aCSF) that was composed of (mM): 124 NaCl, 3 KCl, 26 NaHCO 3 , 2.0 MgSO 4 , 1.2 NaH 2 PO 4 , 2.4 CaCl 2 and 10 glucose; bubbled with 95 percent O 2 -5 percent CO 2 (carbogen). Using a vibratome 1000 (Vibratome 1000 plus; Jed Pella Inc., Redding, CA), several 400 μm coronal sections containing the VTA were cut, transferred to a preincubation chamber and incubated at room temperature (22 ± 1°C) in aCSF for at least 60 minutes. Then, brain slices were incubated in aCSF containing 1 mg/6 ml pronase (Calchem, La Jolla, CA, USA) at 31°C for 25-35 minutes. The VTA area from each slice was then punched out using a well-polished needle punch. Each punched tissue fragment was transferred to a 35-mm culture dish filled with well-oxygenated standard extracellular solution composed of (mM): 150 NaCl, 5 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 glucose and 10 HEPES; pH adjusted to 7.4 with Tris-base. Each tissue fragment was then mechanically dissociated using a fire-polished micro-Pasteur pipette. Isolated single cells usually adhered to the bottom of the dish within 30 minutes and were then used for patch-clamp recording at room temperature within 4 hours. Perforated-patch whole-cell recording techniques (Wu et al. 2004; Yang et al. 2009 ) were employed to determine the effects of JWH133 and/or AM630 on VTA DA neuronal firing under current-clamp recording mode. Pipettes (3-5 MΩ) used for perforatedpatch recordings were filled with intracellular recording solution, which contained (mM): 140 K gluconate, 10 KCl, 5 MgCl 2 and 10 HEPES; pH 7.2 (with Tris-OH) freshly supplemented before use with amphotericin B to 200 μg/ml from a 40 mg/ml DMSO stock. After tight seal (>2 G) formation, it usually took about 5-20 minutes to convert to perforated-patch mode, and an access resistance of 20-60 MΩ was accepted to initiate experiments. Series resistance was not compensated in this study. Data were filtered at 2 kHz, acquired at 10 kHz and digitized on-line (Digidata 1322 series A/D board, Axon Instruments, Foster City, CA). After stable recording for several minutes (baseline), JWH133 or AM630 was bath-applied to the recorded neuron for 1-2 minutes and then washed out. Rapid application of drugs was performed using a computer-controlled 'U-tube' system that allowed for complete exchange of solution surrounding the recorded cell within 30 ms. Data were acquired by Clamplex9.2 (Axon Instruments) via a Digidata 1322 series A/D board set to a sampling frequency of 10 kHz, filtered in Clampfit 9.2 using an 8-pole Bessel filter and a 1-kHz low-pass filter, and stored on hard media for subsequent off-line analysis.
EXPERIMENT 5: IN VIVO MICRODIALYSIS
Surgery
Naive rats were prepared for experimentation by biolateral surgical implantation of intracranial guide cannulae (20 gauge, 14 mm; Plastics One, Roanoke, VA, USA) into NAc (AP +1.6, ML ± 2.0, DV À4.0 mm, 6°f rom vertical) under sodium pentobarbital anesthesia (65 mg/kg, i.p.) using standard aseptic surgical techniques. The intracranial guide cannulae were fixed to the skull with four stainless steel jeweler's screws (Small Parts Inc., Miami Lakes, FL, USA) and dental acrylic.
Microdialysis procedure
The night before the experiment, concentric microdialysis probes (each with 2 mm of dialysis membrane at the tip) were inserted 2 mm beyond the tips of the guide cannulae into the NAc. At 12 hours after probe implantation, dialysis buffer (5 mM KCl, 140 mM NaCl, 1.4 mM CaCl 2 1.2 mM MgCl 2 and 5.0 mM glucose, plus 0.2 mM phosphatebuffered saline to give a pH of 7.4) was perfused through the probe at a rate of 2 μl/min via a syringe pump (Bioanalytical Systems, W. Lafayette, IN). At 2 hours after start of perfusion, microdialysis samples were collected every 20 minutes into 10 μl 0.1 M perchloric acid to prevent DA degradation. After collection, samples were frozen at À80°C. Dialysate DA was measured using high-pressure liquid chromatography with electrochemical detection, as we have reported previously ).
Quantification of DA
Dialysate DA was measured using the ESA electrochemical detection system (ESA Inc., Chelmsford, MA). The DA mobile phase contained 4.76 mM citric acid, 150 mM Na 2 HPO 4 , 3 mM sodium dodecyl sulfate, 50 mM EDTA, 10 percent methanol and 15 percent acetylnitrile and pH5.6. DA was separated using an ESA MD-150 × 3.2 mm reverse phase column and oxidized/reduced using an ESA Coulochem III detector. Three electrodes were used: a pre-injection port guard cell (+0.25 V) to oxidize the mobile phase, a reduction analytical electrode (E1, À0.1 V) and an oxidation analytical electrode (E2, 0.2 V). The area under curve of the DA peak was measured using an 'EZChrom Elite' ESA chromatography data system. DA values were quantified with an external standard curve (generated by three standard concentrations: 10, 100 and 1000 pM). The limit of detection for DA was~1 pM.
EXPERIMENT 6: INTRAVENOUS COCAINE SELF-ADMINISTRATION
Surgery
Animals were prepared for experimentation by surgical catheterization of the right external jugular vein. The jugular catheters were constructed of microrenathane (Braintree Scientific Inc., Braintree, MA, USA), and catheterization was performed under sodium pentobarbital anesthesia (65 mg/kg, i.p.) using standard aseptic surgical techniques. To determine loci of action in rat brain, two additional groups of rats were also surgically implanted with intracranial guide cannulae (20 gauge, 14 mm; Plastics One, Roanoke, VA) into the NAc (shell) (AP +1.7 mm, ML ±2.0 mm, DV À5.0 mm and 6°angle from vertical), with intracranial target coordinates based on the atlas of Paxinos and Watson. Both the self-administration cannulae and intracranial guide cannulae were fixed to the skull with four stainless steel jeweler's screws (Small Parts Inc., Miami Lakes, FL) and dental acrylic. During experimental sessions, each self-administration catheter was connected to an injection pump via tubing encased in a protective metal spring from the head-mounted connector to the top of the experimental chamber. To help prevent clogging, the catheters were flushed daily with a gentamicin-heparin-saline solution (0.1 mg/ml gentamicin, 30 IU/ml heparin; ICN Biochemicals, Cleveland, OH).
Self-administration apparatus
Intravenous self-administration experiments were conducted in operant response test chambers (32 × 25 × 33 cm) from Med Associates Inc. (Georgia, VT). Each test chamber had two levers: 1 active and 1 inactive, located 6.5 cm above the floor. Pressing the active lever activated the infusion pump. Pressing the inactive lever was counted but had no consequence. A cue light and a speaker were located 12 cm above the active lever. The house light was turned on at the start of each 3-hour test session. Scheduling of experimental events and data collection was accomplished using Med Associates software.
Self-administration procedure
After recovery from surgery, each rat was placed into a test chamber (day time-dark phase) and allowed to lever-press for i.v. cocaine (1 mg/kg/infusion) delivered in 0.08 ml over 4.6 seconds, on a fixed ratio 1 (FR1) reinforcement schedule. Each cocaine infusion was associated with presentation of a stimulus light and tone. During the 4.6-second infusion time, additional responses on the active lever were recorded but did not lead to additional infusions. Each session lasted 3 hours. FR1 reinforcement was used for 3-5 days until stable cocaine self-administration was established: operationally defined as a minimum of 20 presses on the active lever per test session, less than 10 percent variability in inter-response interval, less than 10 percent variability in number of infusions taken and less than 10 percent variability in number of presses on the active lever for at least three consecutive days. Subjects were then allowed to continue self-administration cocaine (0.5 mg/kg/infusion) under FR2 reinforcement. This dose of cocaine was chosen based on previous studies showing that 0.5 mg/kg/infusion of cocaine lies within the middle range of the descending limb of the cocaine dose-response selfadministration curve, where reliable dose-dependent effects are observed (Xi et al. 2005) . To avoid cocaine overdose, each animal was limited to a maximum of 50 cocaine injections per 3-hour session.
Evaluating the effects of JWH133 on cocaine selfadministration We have recently reported that systemic administration of JWH133 or AM630 failed to alter cocaine self-administration (Zhang et al., 2015) . In this experiment, we further observed the effects of local administration of JWH133 into the NAc on cocaine self-administration under FR2 (within-subjects design, n = 10) or progressive-ratio (within-subjects design, n = 7) reinforcement, respectively. On the test day, each animal randomly received bilateral intracranial microinjections of vehicle or one of two doses of JWH133 (1 or 3 μg/μl/side, 30 minutes prior to test). A total of 0.5 μl was injected into each NAc over 1 minutes, and the injectors were then kept in place for an additional 1 minutes. The doses of JWH133 were based on pilot preliminary observations and a previous study (Xi et al. 2011) . Cannula placements were verified after the completion of experiments by standard histological and anatomic localization techniques.
Sucrose self-administration
To determine whether brain CB 2 R up-regulation is cocaine-specific and whether drug self-administration procedure alters CB 2 R expression, we further observed the effects of operant sucrose self-administration on brain CB 2 R mRNA expression in rats. The sucrose selfadministration procedures were identical to the procedures for cocaine self-administration except that no i.v. surgery was performed on the animals in the sucrose experiment and that active lever presses led to delivery of 0.1 ml of 5 percent sucrose solution into a liquid food tray on the operant chamber wall.
DRUGS
Cocaine HCl (Sigma-Aldrich) was dissolved in physiological saline. JWH133 and AM630 were obtained from Tocris Bioscience division of Biotechnology (Minneapolis, MN) and dissolved in Tocrisolve-100 (vehicle).
STATISTICAL ANALYSIS
Data are presented as means ± SEM. One-way analysis of variance (ANOVA) was used to determine the significance of changes in each measurement described in the preceding texts. Post hoc individual group comparisons were carried out using the Student-Newman Keuls method.
RESULTS
CB 2 mRNA is expressed in rat VTA DA neurons
To study whether rat CB 2 (rCB 2 ) gene is present in VTA DA neurons, we used a novel, highly sensitive RNA ISH method (RNAscope) (Wang et al. 2012 ). We initially designed three RNAscope probes that target different gene sequences. We found only one probe that targets the 3′-untranslated region (UTR) to work well. This probe is long (908 bp) and displays high rCB 2 specificity because it does not hybridize with the CB 1 or other genes as determined by cross-checking the host genomic background (Advanced Cell Diagnositics, Inc., Hayward, CA). Figure 1 shows CB 2 mRNA-staining (green dots) in VTA DA (DAT-mRNA-positive) neurons (yellow dots in merged images) and also in VTA non-DA cells (DAT-mRNA-negative, green dots around blue nuclei in merged images) in drug naïve (Fig. 1a) and in cocaine self-administration (Fig. 1b) rats. CB 2 mRNA and DAT-mRNA are co-localized in VTA DA neurons. Quantitative dot/pixel counting indicated that cocaine self-administration significantly up-regulated CB 2 mRNA expression in VTA DA neurons ( Fig. 1c; F 1 , 140 = 126.78, p < 0.001). To further confirm this finding, we used quantitative RT-PCR to compare CB 2 mRNA expression in various brain regions. We found that cocaine, but not sucrose, self-administration significantly up-regulated CB 2 mRNA expression in prefrontal cortex (F 2, 13 = 6.2, p < 0.05), striatum (including the NAc, Fig. 1d ; F 2, 13 = 6.55, p < 0.05) and VTAcontaining midbrain tissues (F 2, 13 = 5.23, p < 0.05).
CB 2 R proteins are expressed in VTA DA neurons
We then examined CB 2 R protein expression in VTA DA neurons using IHC assays. Figure 2a shows the binding site (epitope) of the Alomone rCB 2 antibody used to detect CB 2 -immunostaining in this study. Figure 2b shows rCB 2 -immunostaining with this antibody in the absence or presence of immune peptide, illustrating that rCB 2 R-staining was detected in VTA neurons and was blocked by an immune peptide that preabsorbed the rCB 2 antibody. Figure 2c shows rCB 2 and tyrosine hydroxylase (TH) immunostaining in the whole midbrain, illustrating that rCB 2 -immunostaining is very weak or undetectable under low magnification (10×) in the VTA and substantia nigra pars compacta of rats. However, under high magnification (40×), rCB2-immunostaining was clearly seen in neuronal cells in the VTA (refer to the inserted image in Figure 1 RNA in situ hybridization results, illustrating cannabinoid CB 2 mRNA expression (green) in VTA DA neurons of naïve rats (a) and cocaine selfadministration rats (b) measured by RNAscope ISH. A DAT probe was used to label VTA DA neurons (red) and DAPI was used to label cell nuclei (blue). c: Quantitative assay results in RNAscope ISH assays, illustrating that cocaine self-administration significantly increased CB 2 mRNA expression in VTA DA neurons. d: Quantitative RT-PCR results, illustrating that chronic cocaine self-administration (4 weeks) significantly up-regulated CB 2 mRNA expression in prefrontal cortex (PFC), striatum (STR) and midbrain. *p < 0.05, ***p < 0.001, compared with naïve rats (c, d) or sucrose SA rats (d). SA: self-administration Fig.2c, upper panel) . Figure 2d /e shows double-label immunostaining, illustrating that CB 2 -immunostaining is co-localized with TH in VTA DA neurons (TH-positive, white arrows). In addition, CB 2 R-immunostaining is also seen in TH-negative non-DA neurons (white arrow-heads).
Activation of CB 2 Rs inhibits VTA DA neuronal firing Next, we examined whether activation of CB 2 Rs in the VTA functionally alters neuronal firing in single dissociated VTA DA neurons using patch-clamp recording. Identification of DA neurons was based on the following three criteria (Wu et al. 2004; Yang et al. 2009 ): (1) electrophysiology: DA neurons exhibited low spontaneous firing rates (1-3 Hz, Fig. 3a-b ) with long AP duration (Fig. 3a-c) , and a distinctive H-current (Fig. 3a-d) , while GABA neurons exhibited relatively high firing rates (Fig. 3b-b ) with short AP duration (Fig. 3b-c) , and no H-current ( Fig. 3b-d) ; (2) pharmacology: DA (or D 2 receptor agonist, not shown here) administration inhibited DA (Fig. 3a-b) , but not GABA (Fig. 3b-b) , neuronal firing; and (3) IHC staining: the recorded neuron was labeled with Lucifer yellow and showed positive TH-immunostaining (Fig. 3a-a) ; the GABA neurons showed TH-negative (Fig. 3b-a) . Figure 3c shows representative recording of low firing rate of a DA neuron (~1 Hz) (Fig. 3c-a) ; bathapplied JWH133 (1 μM) reduced the neuronal firing rate (Fig. 3c-b) . Figure 3d shows that JWH133 dosedependently inhibited VTA DA neuronal firing, an effect that was blocked by co-administration of AM630 (a selective CB 2 R antagonist, 1 μM). Figure 3e shows that JWH133 (1 μM) hyperpolarized the resting membrane Figure 3 Electrophysiological assays in rats, illustrating that activation of CB 2 Rs by JWH133 inhibits neuronal firing in single dissociated VTA DA neurons. a: Identification of VTA DA neurons, illustrating a representative dissociated DA neuron (phase contrast, Lucifer yellow labeled and TH stained images, a-a), the effect of DA on neuronal firing (a-b), and on action potential (AP) profiles. VTA DA neurons exhibited low firing rates (1-3 Hz) with relatively long AP duration (a-c) and a characteristic H-current (ad). b: Identification of VTA GABA neurons, illustrating a representative dissociated GABA neuron (ba), the effect of DA on neuronal firing (b-b), and AP profiles. VTA GABA neurons exhibited high firing rates (>7 Hz, bb) with short AP durations (b-c) and did not show H-currents (b-d). c: Representative trace of spontaneous neuronal firing before (c-a) and after (c-b) JWH133 (1 μM). d: group mean data, illustrating that JWH133 dose-dependently inhibited VTA DA neuronal firing, an effect that was blocked by AM630. e: Bath-applied JWH133 (1 μM) hyperpolarized resting membrane potential, potentiated the after-hyperpolarization potential, but had no effect on AP amplitude and duration. The number in the each column indicates neuronal numbers tested for each treatment. *p < 0.05, compared with baseline potential and augmented the after-hyperpolarization potential (AHP), but had no effect on AP amplitude or duration. Figure 4a shows that systemic administration of JWH133 (10, 20 mg/kg) failed to alter basal extracellular DA level compared with pre-JWH133 baselines. However, local perfusion of JWH133 into the NAc significantly lowered extracellular DA level ( Fig. 4b; F 2,13 = 4 .10, p < 0.01). Post hoc individual group comparisons revealed a significant reduction in extracellular DA after 10 or 100 μM JWH133 compared with baseline level before JWH133 perfusion. This effect was blocked by pretreatment with AM630 before intra-NAc local JWH133 perfusion. AM630 alone (10 mg/kg, i.p.) had no effect on extracellular NAc DA (Fig. 4b) .
Activation of CB 2 Rs inhibits DA release in the nucleus accumbens
Consistent with the previously mentioned findings, systemic administration of JWH133 (10, 20 mg/kg, i.p., 40 minutes prior to cocaine) failed to alter cocaine-induced increases in extracellular DA ( Fig. 4c ; F 2,19 = 0.62, p > 0.05). However, intra-NAc local administration of JWH133 (100 μM) significantly attenuated cocaineinduced increases in extracellular DA (Fig. 4d) . Two-way ANOVA for repeated measures over time revealed a significant JWH133 treatment main effect (F 1,14 = 11.25, p < 0.01), time main effect (F 8,112 = 26.29, p < 0.001) and treatment × time interaction (F 8,112 = 8.96, p < 0.001). Post hoc individual group comparisons revealed a significant reduction in cocaine-enhanced DA in the presence of JWH133 in the NAc.
CB 2 R activation inhibits cocaine self-administration
We have recently reported that systemic administration of JWH133 has no effect on i.v. cocaine selfadministration (Zhang et al. 2015) . Here, we further examined whether local administration of JWH133 into the NAc inhibits cocaine self-administration. Figure 5 shows that bilateral microinjections of JWH133 (1, 3 μg/μl/side) into the NAc significantly inhibited cocaine self-administration under FR2 reinforcement schedule (F 2,27 = 4.10 , p < 0.05, one-way ANOVA). Figure 5b shows that microinjections of JWH133 into the NAc also significantly lowered the break-point levels for cocaine self-administration under progressive-ratio (PR) reinforcement (F 2,18 = 5.21, p < 0.01).
DISCUSSION
The major findings of the present study are (1) CB 2 R mRNA and proteins are expressed in VTA DA neurons (and also non-DA neurons) in rats; (2) cocaine self-administration up-regulates CB 2 mRNA expression in the prefrontal cortex and striatum and in VTA DA neurons; and (3) activation of CB 2 Rs by JWH133 inhibits VTA DA neuronal firing, NAc DA release and i.v. cocaine self-administration. These findings suggest that CB 2 Rs are expressed in VTA DA neurons and functionally modulate mesolimbic DA release and cocaine selfadministration behavior in rats. To determine whether CB 2 Rs are expressed in rat VTA DA neurons, we used multiple approaches, including highly sensitive RNAscope ISH, qRT-PCR, IHC, electrophysiology, neurochemistry, behavioral pharmacology, use of the highly-selective CB 2 R agonist (JWH133) and antagonist (AM630) and multiple methods of drug delivery (systemic, intra-NAc, bath-applied). All the present findings converge to support the same conclusion that functional CB 2 Rs are expressed in the mesolimbic DA system. We note that antibody specificity has been an issue in this field for many years (Ashton 2012; Atwood & Mackie 2010) . We have tested up to 10 different CB 2 antibodies in the IHC assays by the use of WT, CB 1 -KO and CB 2 -KO mice as controls. We found none of them to be absolutely CB 2 specific. However, the presently used Alomone CB 2 antibody displays a high degree of CB 2 specificity, as assessed by an~70 percent reduction in the density of CB 2 -immunostaining in VTA DA neurons in CB 2 -KO mice compared with that in WT mice (Zhang et al. 2014 ). Because of this IHC limitation, we were forced to use additional approaches to study CB 2 R expression in VTA DA neurons.
Importantly, the CB 2 mRNA signal detected by RNAscope ISH technology is highly rCB 2 -specific. This technique uses unique 20 double Z probe design across 1 kb region of CB 2 R 3′-UTR that allows simultaneous target-signal amplification and background suppression. Thus, it tremendously lowers nonspecific binding and significantly increases target-signaling specificity. It is therefore highly sensitive to very low RNA signals, even from a single copy of a gene (Wang et al. 2012) . A computerscreened probe assay also supports the specificity of the presently-utilized CB 2 RNAscope probe because it exhibits no homology or cross hybridization to the cannabinoid CB 1 or other genes. Using both ISH and IHC assays, we detected clear CB 2 gene and receptor expression in VTA DA neurons in rats. This is consistent with other recent reports that CB 2 mRNA is expressed in VTA (DA) neurons in mice (Aracil-Fernandez et al. 2012; Zhang et al. 2014; Zhang et al. 2015) , in hippocampal neurons in mice , and in striatal GABAergic neurons in non-human primates (Lanciego et al. 2011; Sierra et al. 2015) .
The previously mentioned findings using ISH and IHC assays are further supported by our electrophysiological results demonstrating that bath-applied JWH133 significantly inhibits VTA DA neuronal firing and produced VTA DA neuronal hyperpolarization in single dissociated VTA DA neurons, which provides direct functional evidence supporting CB 2 R expression in VTA DA neurons in rats. This is further supported by our finding that intra-NAc local administration of JWH133 significantly inhibited basal DA release, cocaine-induced increase in NAc DA and cocaine self-administration. These effects were blocked by co-administration of AM630, a selective CB 2 R antagonist, suggesting CB 2 R-mediated effects. All these findings support a common conclusion that CB 2 Rs Figure 5 Effects of intra-NAc local administration of JWH133 on cocaine self-administration in rats. a: Microinjections of JWH133 into the NAc inhibited cocaine self-administration under FR2 reinforcement; b: intra-NAc microinjections of JWH133 lowered break-point levels for cocaine self-administration under PR reinforcement conditions. *p < 0.05, compared with vehicle control group are expressed and are functional in VTA DA neurons in rats. We have recently reported that JWH133 is a highly selective CB 2 R agonist because deletion of CB 2 Rs, not CB 1 Rs, abolished the action produced by JWH133 (Xi et al. 2011; Zhang et al. 2014) . Because of lack of CB 2 -KO rats as controls in the present study, in theory, we cannot completely exclude possible involvement of non-CB 1 and non-CB 2 R mechanisms in JWH133 action in rats. In addition, CB 2 mRNA and immunostaining are also seen in some non-DA neurons in the VTA, suggesting that non-DA mechanisms may also contribute to the behavioral effects of JWH133 in the previously mentioned cocaine self-administration experiments.
We reiterate that systemic administration of JWH133 had no effect on either DA release in the NAc (present study) or i.v. cocaine self-administration in rats (Zhang et al. 2015) . Similarly, systemic administration of AM1241, another putative CB 2 R agonist, failed to alter nicotine self-administration in rats (Gamaleddin et al. 2012) . The reason(s) for the ineffectiveness are unclear. One possibility is that JWH133 may have relatively poor bioavailability in rats. Therefore, higher systemic doses of JWH133 may be required to produce significant neurochemical and behavioral effects. Unfortunately, we cannot test this hypothesis because a higher dose (50 mg/kg) of JWH133 produced significant sedation and locomotor impairment in our pilot studies. The second possibility is that CB 2 Rs have broad distributions in rat brain. Thus, JWH133-induced reduction in NAc DA release and cocaine self-administration may be compromised by its actions in other brain regions after systemic administration. A third possibility is species differences in CB 2 R structures in rats and mice Zhang et al. 2015) . There are four CB 2 mRNA isoforms identified in rats, but only two isoforms identified in mice Zhang et al. 2015) . CB 2 Rs display 90 percent, 81 percent and 79 percent homology in amino acid sequences between rat and mouse, human and rat and human and mouse, respectively. More importantly, rat CB 2 R is 13 amino acids longer in its intracellular C-terminal than mouse CB 2 Rs (Zhang et al. 2015) . These data suggest that CB 2 Rs may have different affinity or sensitivity to JWH133 or other ligands in rats and mice. In consistent with this view, JWH133 was reported to be more selective for hCB 2 Rs (200-fold) over rCB 2 Rs, while AM630 is more potent at rCB 2 Rs than at hCB 2 Rs (Huffman 2005; Marriott et al. 2006 ). AM1241 has higher affinity for hCB 2 Rs over rCB 2 Rs and over mCB 2 Rs (Bingham et al. 2007; Yao et al. 2006 ). Finally, the present studies demonstrate that CB 2 Rs display similar cellular distributions and functioning in VTA DA neurons in rats and mice, suggesting that the ineffectiveness of JWH133 after systemic administration in rats is more likely because of other mechanisms, rather than different CB 2 R distributions in VTA DA neurons in rats and mice. Taken together, all these findings suggest that ligand binding and efficacy data cannot be automatically extrapolated from one species to another; thus, speciesspecific CB 2 R agonists or antagonists may be required in medication development for treatment of CNS disorders that are therapeutically amenable to CB 2 R-mediated manipulations.
We note that the present finding that intra-NAc microinjections of JWH133 significantly inhibit cocaine self-administration appears different from our previous reports that systemic administration of JWH133 produced biphasic effects-lower doses increased, while higher doses decreased break-point for cocaine selfadministration under PR reinforcement (Zhang et al. 2015) . This may be related to the fact that PR cocaine self-administration is very sensitive to small changes in drug's rewarding efficacy (Richardson & Roberts 1996) . Thus, it is likely that the enhanced PR break-point could be a compensatory response in motivation for drugtaking to reduced cocaine reward after low doses of JWH133, while the reduction in PR break-point could be simply interpreted as cessation of cocaine-taking because of reinforcement blockade after high doses of JWH133 (Zhang et al. 2015) . Thus, all these findings support a common conclusion that activation of brain CB 2 Rs inhibits cocaine reward, which may leads to different alterations in cocaine self-administration under different experimental conditions. Finally, we should point out that brain CB 2 mRNA levels are very low compared with levels in spleen (Zhang et al. 2014 ). However, low densities of CB 2 mRNA in brain do not necessarily mean low levels of CB 2 R expression. Actually, a moderate density of CB 2 R-immunostaining is detected in DA neurons under high magnification (40×) in the VTA (present study) (Aracil-Fernandez et al. 2012; Zhang et al. 2014 ) and in neurons in many other brain regions (Ashton et al. 2006; Baek et al. 2013; Gong et al. 2006) . Although antibody specificity is of concern because of a lack of full CB 2 -KO mice as controls, it would be imprudent to conclude that the immunostaining detected in the previously mentioned experiments are absolutely not CB 2 specific and that low levels of mRNA certainly imply low levels of CB 2 R expression. Brain opioid receptor mRNA levels are also very low, and there is no highly selective opioid receptor antibody available (Mansour et al. 1994; Mansour et al. 1995 ). Yet, the presence of functional opioid receptors in brain is not disputed, as they are detected by many other functional and pharmacological methods such as autoradiography. Although autoradiography assays have not been used to study brain CB 2 R expression, multiple radiolabel CB 2 R agonists have been developed and have been successfully used to study brain CB 2 R expression by microPET imaging techniques (Hortala et al. 2014; Horti et al. 2010; Savonenko et al. 2015; Yrjola et al. 2015) . Second, many recent studies suggest that brain CB 2 Rs are inducible or up-regulated in response to various types of insults Pacher & Mechoulam 2011; Shohami et al. 2011) , such as chronic pain (Beltramo et al. 2006; Luongo et al. 2010) , ischemiainduced hypoxia (Ashton et al. 2007 ), neuroinflammation (Atwood & Mackie 2010; Benito et al. 2008 ) and several chronic CNS disorders such as Alzheimer's disease, HIV-induced encephalitis and multiple sclerosis (Benito et al. 2008) . In the present study, we found that chronic cocaine self-administration also significantly up-regulated CB 2 mRNA expression in brain and in VTA DA neurons. Such CB 2 R up-regulation observed in cocaine selfadministration rats may in part explain the ameliorative effects of CB 2 R ligands on cocaine or alcohol selfadministration (Al Mansouri et al. 2014; Xi et al. 2011; Zhang et al. 2014; Zhang et al. 2015) , cocaine-induced or nicotine-induced CPP (Ignatowska-Jankowska et al. 2013; Navarrete et al. 2013) , cocaine-induced reinstatement of drug-seeking behavior (Adamczyk et al. 2012) and cocaine-induced conditioned locomotion (Blanco-Calvo et al. 2014) .
In summary, the present findings demonstrate that cannabinoid CB 2 gene and receptors are expressed and up-regulated by cocaine in midbrain VTA DA neurons in rats. Activation of CB 2 Rs inhibits VTA DA neuronal firing, NAc DA release and DA-regulated cocaine self-administration behavior. Given the important role of DA and cannabinoid CB 2 Rs in substance abuse and addiction, food-taking and other DA-related neuropsychiatric disorders, the present findings suggest that brain CB 2 Rs may constitute new targets in medication development for treatment of such CNS disorders.
